Related Experiment Video
Updated: Apr 30, 2026

08:56
Evaluating the Role of Mitochondrial Function in Cancer-related Fatigue
Published on: May 17, 2018
8.6K
Urinary metabolites and fatigue in a population-based metabolomics study: an exploratory analysis
Annika Kneipp1, Inge Kirchberger1, Dennis Freuer1
1Institute of Epidemiology, Faculty of Medicine, University of Augsburg, 86156, Augsburg, Germany.
Metabolomics : Official Journal of the Metabolomic Society
|April 28, 2026
Summary
Chronic fatigue affects many adults, but its causes are unclear. This study found links between urinary metabolites, like hypoxanthine, and fatigue, suggesting potential biological pathways.
Area of Science:
- Metabolomics
- Biochemistry
- Human Health
Background:
- Chronic fatigue is prevalent, affecting nearly 20% of adults.
- The etiology and underlying mechanisms of chronic fatigue remain poorly understood.
- Metabolomics offers novel approaches to identify disease-related metabolites.
Purpose of the Study:
- To investigate the association between urinary metabolites and fatigue in the general population.
- To explore potential biochemical markers and mechanisms related to fatigue.
Main Methods:
- Utilized the Fatigue Assessment Scale (FAS) to measure fatigue severity.
- Quantified 51 urinary metabolites using ¹H nuclear magnetic resonance (¹H-NMR).
- Employed multivariable linear regression models with adjustment for confounders in 570 participants from the MEIA study.
Main Results:
- Four urinary metabolites (hypoxanthine, 3-hydroxyhippurate, dimethylamine, trimethylamine-N-oxide) initially showed significant associations with fatigue.
- Hypoxanthine's association was particularly noted in individuals with obesity (BMI ≥ 30 kg/m²).
- After adjusting for multiple testing (false discovery rate), no associations remained statistically significant.
Conclusions:
- Urinary metabolites linked to purine degradation and gut microbial metabolism may indicate fatigue-related biological processes.
- Urinary metabolomics shows promise for identifying biochemical alterations and potential pathophysiological mechanisms of fatigue.
- Further research is needed to validate these findings and elucidate the role of specific metabolites in fatigue.
More Related Videos
Related Concept Videos
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
324
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
324
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
399
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
399

